Artikel von Marvin Herzberger
Marvin Herzberger is a publishing trader at TraderFox GmbH and group leader for the technical analysis of the DAX. He has been actively engaged in technical analysis since 2011. In this context, he has tested, analyzed, and evaluated various trading strategies in practical implementation. His area of expertise lies in swing trading. The analyses cover a short-term time horizon of up to 10 days.Latest from Marvin Herzberger
Tenable Holdings: Experts see massive upside potential of 118%!
In April 2026, the entire software sector initially faced significant turbulence, triggered by a broad...
Sixt: Record Revenues, Global Growth, and a Two-Million-Euro Vote of Confidence!
Sixt SE has shown a dynamic comeback in recent weeks. The company has transformed from a traditional...
Eckert & Ziegler: Metzler Praises the Record Margins and low Valuation!
Eckert & Ziegler SE (i.) is a highly specialized and globally leading company in the field of isotope...
Nike: New Wave of Innovation and a $670,000 Vote of Confidence from Insiders!
Nike Inc. (NKE) is the world's leading provider of sports shoes, apparel, and equipment. The company...
Verastem: Strong Study Data and Over 200% Price Potential Electrify Wall Street
Successful Market Launch and Positive Company Outlook Verastem Inc. (VSTM) is currently in a crucial...
Robinhood: I see the current consolidation as an attractive buying opportunity!
Since the peak in mid-December, the stock price of Robinhood Markets (HOOD) (i.) has approximately halved....
Corcept Therapeutics: FDA Approval as a Gamechanger - Oncology Breakthrough as a Price Driver
FDA Approval as a Historic Milestone For Corcept Therapeutics (CORT) , late March 2026 marks a pivotal...
Roblox: Underrated Earnings Potential and Why Bank of America Sets a $165 Price Target!
March 2026 is all about strategic development and strengthening its own ecosystem for Roblox Corporation...
Sibanye Stillwater: With Record Profits and Massive Insider Purchases to a {[Global Leader]} in the Energy Transition
Sibanye Stillwater Limited (SBSW) positions itself as a globally leading, multinational mining and metal...
INDUS Holding AG: The Silent Giant of the Medium-Sized Enterprises!
INDUS has focused as an investment company on highly specialized medium-sized manufacturing companies....
Buy Alert for Smithfield Foods: Record Figures and Strategic Acquisitions are Likely to Drive Growth Further!
Dear investors, Smithfield Foods Inc. (SFD) is an American food company that has established itself...
INDUS Holding AG: Record Orders and Higher Dividend – How the Network of Hidden Champions Remains on a Growth Path
INDUS Holding AG invests according to the "Buy, Hold & Develop" principle in technologically...
Hut 8 Mining: Arete Research Sees 177% Price Potential!
The recent rating by the research firm Arete Research on March 23 marks a significant vote of confidence...
Insmed's Masterpiece: From Niche Player to Billion-Dollar Heavyweight
Insmed (i.) is a pharmaceutical company that specializes in the development of medications for people...
Insmed: Double Strike in Rare Lung Diseases Unleashes New Billion-Dollar Potential
Insmed Inc. (INSM) is a biotechnology company specializing in therapies for severe and rare diseases....
RWE AG: From Coal Dinosaur to AI Beneficiary!
RWE AG has undergone an impressive transformation from a fossil corporation to an agile beneficiary of...
Larimar Therapeutics: Analysts Predict Massive Upside Potential of Up to 430%
Regulatory Breakthrough and Strategic Milestones Larimar Therapeutics (LRMR) (still listed under...
Firefly Aerospace: USD 1.4 Billion Backlog Could Trigger Revenue Jump in 2026!
Firefly Aerospace (FLY) (i.) positions itself as a leading technology company for the civil, commercial,...
UP Fintech Holding Ltd.: Record Numbers and Smart Innovations - {Trend Reversal} is Being Accelerated!
UP Fintech Holding Ltd. (TIGR) positions itself as a leading online broker with a global reach. Through...
Olema Pharmaceuticals: Billion Market in Sight – Why Analysts See Huge Price Potentials Now
Operational Progress and the Path to Commercial Phase Olema Pharmaceuticals (OLMA) is in a critical...